Please login to the form below

Not currently logged in
Email:
Password:

New accounts: November

The following tables list new pharmaceutical account wins notified to us by the winning agencies for the period August to October 2005 inclusive

The following tables list new pharmaceutical account wins notified to us by the winning agencies for the period August to October 2005 inclusive. Please note that inclusion in this table does not necessarily indicate exclusivity and other agencies may also be involved with some of the products listed in other ways, or in domestic, overseas or international markets. To submit an entry for New Accounts, email nhobson@pmlive.com.

Bristol-Myers Squibb

New product

Ultrasound contrast agents

PAN Advertising

Cardinal Health

Physeptone

Addiction

Lowe Azure

Cardinal Health Martindale Products

Pre-filled syringes

Hospital speciality

Pulsar Healthcare Communications

Link Pharmaceuticals

Gliadel implant

Oncology

Addjuice

Mayne Pharma

N/A

Full portfolio

Swordfish Advertising

Napp Pharmaceuticals

BuTrans

Pain relief

Langland

Roche

New product

Oncology

MJL

Royal Free Hospital

Fundraising

HIV/HCV/HBV

MJL

Royal Numico (global)

Cubitan

Woundcare nutrition

central

Royal Numico (global)

Cubison

Woundcare nutrition

central

Wyeth

Efexor XL

Psychiatry

PAN Advertising

2nd September 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
COUCH.

WE ARE COUCH – a full service medical communications agency. We are a trusted partner; always striving to help make...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics